News + Events
11.11.08 CODA Genomics, Inc. Changes
Company
Name to Verdezyne
10.27.08 CODA Genomics Names Stephen
Picataggio to Chief Scientific Officer
10.14.08 CODA Genomics Signs Collaboration
Agreement with Genencor |
Verdezyne employs its biology expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to direct the evolution of novel metabolic pathways for cost effective commercial production of biofuels and platform chemicals. |